Back
Markel Group Vs. Aligos Therapeutics Industry Stock Comparison
Buy
54
MKL
Markel Group
Last Price:
$1,732.00
Seasonality Move:
7.78%
Buy
65
ALGS
Aligos Therapeutics
Last Price:
$41.28
Seasonality Move:
-16.03%
Buy
54
Markel Group (MKL)
is a Buy
Is Markel Group a Buy, Sell or Hold?
-
The current Markel Group [MKL] share price is $1,752.13. The Score for MKL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
MKL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MKL Stock Price Chart
What is Markel Group's stock price today?
-
The Markel Group share price today is $1,752.13Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MKL is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $43.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MKL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 12.69 | Buy |
Relative Strength Index (14 RSI): | 58.93 | Buy |
Chaikin Money Flow: | 2046 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1716.48 - 1769.22) | Buy |
Bollinger Bands (100): | (1532 - 1699.58) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.71 | Buy |
Relative Strength Index (14 RSI): | 81.52 | Buy |
Chaikin Money Flow: | 630913 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.74 - 36.8) | Buy |
Bollinger Bands (100): | (6.83 - 25.23) | Buy |
MKL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1722.97 | Buy |
20-day SMA: | 1743.57 | Buy |
50-day SMA: | 1675.22 | Buy |
200-day SMA: | 1585.35 | Buy |
8-day EMA: | 1735.45 | Buy |
20-day EMA: | 1728.69 | Buy |
50-day EMA: | 1688.68 | Buy |
200-day EMA: | 1590.85 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.61 | Buy |
20-day SMA: | 32.22 | Buy |
50-day SMA: | 20.6 | Buy |
200-day SMA: | 16.51 | Buy |
8-day EMA: | 38.12 | Buy |
20-day EMA: | 32.66 | Buy |
50-day EMA: | 24.43 | Buy |
200-day EMA: | 18.11 | Buy |
Markel Group Earnings Growth & MKL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.94 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.03 per share, and an increase next year of $11.15 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Markel Group Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |